NCT00951535 2026-04-17
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Cancer Trials Ireland
Phase 2 Active not recruiting
Cancer Trials Ireland
Mayo Clinic
Emory University
University of Utah
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Radiation Therapy Oncology Group
Fundacion IMIM
UNICANCER
Samsung Medical Center